Wellfully (ASX:WFLOA) Days Payable: 70,171.25 (As of Dec. 2023) — 27618% Above Median


What is Wellfully Days Payable?

Wellfully ASX:WFLOA Days Payable is 70,171.25 as of Dec. 2023, which is 27618% above its 10-year median of 253.16. The stock has 7 warning signs investors should review.

Wellfully's average Accounts Payable for the six months ended in Dec. 2023 was A$3.85 Mil. Wellfully's Cost of Goods Sold for the six months ended in Dec. 2023 was A$0.01 Mil. Hence, Wellfully's Days Payable for the six months ended in Dec. 2023 was 70,171.25.

The historical rank and industry rank for Wellfully's Days Payable or its related term are showing as below:

ASX:WFLOA' s Days Payable Range Over the Past 10 Years
Min: 101.5   Med: 253.16   Max: 404.82
Current: 2024.57

During the past 13 years, Wellfully's highest Days Payable was 404.82. The lowest was 101.50. And the median was 253.16.

ASX:WFLOA's Days Payable is not ranked
in the Medical Diagnostics & Research industry.
Industry Median: 65.385 vs ASX:WFLOA: 2024.57

Wellfully's Days Payable increased from Dec. 2022 (326.20) to Dec. 2023 (70,171.25). It may suggest that Wellfully delayed paying its suppliers.


Wellfully Days Payable Historical Data

* Premium members only.

The historical data trend for Wellfully's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Wellfully Days Payable Chart

Wellfully Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Days Payable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 101.50 404.82

Wellfully Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Days Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 84.14 129.37 326.20 878.59 70,171.25

ASX:WFLOA vs TMO, DHR, IDXX: Days Payable Comparison

For the Diagnostics & Research subindustry, Wellfully's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Wellfully Days Payable vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Wellfully's Days Payable distribution charts can be found below:

* The bar in red indicates where Wellfully's Days Payable falls into.



Wellfully Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Wellfully's Days Payable for the fiscal year that ended in Jun. 2023 is calculated as

Days Payable (A: Jun. 2023 )
=Average Accounts Payable /Cost of Goods Sold*Days in Period
=( (Accounts Payable (A: Jun. 2022 ) + Accounts Payable (A: Jun. 2023 )) / count ) / Cost of Goods Sold (A: Jun. 2023 )*Days in Period
=( (0.589 + 3.071) / 2 ) / 1.65*365
=1.83 / 1.65*365
=404.82

Wellfully's Days Payable for the quarter that ended in Dec. 2023 is calculated as:

Days Payable (Q: Dec. 2023 )
=Average Accounts Payable / Cost of Goods Sold*Days in Period
=( (Accounts Payable (Q: Jun. 2023 ) + Accounts Payable (Q: Dec. 2023 )) / count ) / Cost of Goods Sold (Q: Dec. 2023 )*Days in Period
=( (3.071 + 4.619) / 2 ) / 0.01*365 / 2
=3.845 / 0.01*365 / 2
=70,171.25

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Days Payable →
What does a Days Payable of 70,171.25 mean?
Wellfully (ASX:WFLOA) has a Days Payable of 70,171.25 as of Dec. 2023. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Wellfully and its competitors. This is 27618% above median its historical median of 253.16. Over the past decade, Wellfully's Days Payable has ranged from 101.50 to 404.82.
Is Wellfully's Days Payable too high?
Wellfully's current Days Payable of 70,171.25 is 27618% above median its 10-year median of 253.16. Over the past 10 years, this metric has ranged from a low of 101.50 to a high of 404.82. The Medical Diagnostics & Research industry median Days Payable is 65.39. Wellfully's value of 70,171.25 is 107220.1% above this industry median.
How does Wellfully's Days Payable compare to TMO and DHR?
Wellfully's Days Payable of 70,171.25 can be compared against companies in the Medical Diagnostics & Research industry. The industry median Days Payable is 65.39. Wellfully's value of 70,171.25 is 107220.1% above this benchmark. Historically, Wellfully's own Days Payable has ranged from 101.50 to 404.82 over the past decade. While the company's 10-year median is 253.16 vs. the industry median of 65.39, Wellfully has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Diagnostics & Research company?
The median Days Payable among Medical Diagnostics & Research companies is 65.39, based on 190 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Wellfully's current Days Payable of 70,171.25 is 107220.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Wellfully and its competitors. For the Medical Diagnostics & Research industry, the median Days Payable is 65.39 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Wellfully's current Days Payable is 70,171.25, which is 27618% above median its own 10-year median of 253.16. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Wellfully stock overvalued right now?
Wellfully (ASX:WFLOA) has a current Days Payable of 70,171.25. The current Days Payable is 70,171.25, which is 27618% above median its 10-year median of 253.16 and 107220.1% above the Medical Diagnostics & Research industry median of 65.39. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Wellfully (ASX:WFLOA), the current Days Payable is 70,171.25 as of Dec. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Wellfully Business Description

Address 284 Oxford Street, Ground Floor, Leederville, WA, AUS, 6007
Wellfully Ltd is engaged in the research and development of Dermaportation and ETP transdermal drug delivery technologies. The company operates in segments namely the development of the dermaportation drug delivery technology and Devices segments. Geographically, it derives a majority of its revenue from Europe and also has a presence in Japan. It serves the Pharmaceutical; Cosmetics Skincare and Consumer Healthcare industries.